This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dominiczak, A. F. Articles by Reid, J. L. Search for Related Content PubMed PubMed Citation Articles by Dominiczak, A. F. Articles by Reid, J. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information High Blood Pressure Hazardous Substances DB LOSARTAN POTASSIUM

(Hypertension. 1996;27:752-759.)
© 1996 American Heart Association, Inc.

Articles

Vascular Smooth Muscle Polyploidy and Cardiac Hypertrophy in Genetic Hypertension

Anna F. Dominiczak; Alison M. Devlin; Wai K. Lee; Niall H. Anderson; David F. Bohr; John L. Reid

From the Departments of Medicine and Therapeutics (A.F.D., A.M.D., W.K.L., J.L.R.) and Robertson's Centre for Biostatistics (N.H.A.), University of Glasgow (Scotland, UK), and Department of Physiology, University of Michigan, Ann Arbor (D.F.B.).

Correspondence to Anna F. Dominiczak, Department of Medicine and Therapeutics, University of Glasgow, Western Infirmary, Glasgow G11 6NT, Scotland, UK.

Abstract We studied the mechanisms responsible for vascular and cardiac hypertrophy in hypertension (pressure load and humoral and genetic factors) in two experimental approaches: (1) We carried out a cosegregation analysis to correlate cardiac and vascular hypertrophy with subphenotypes of blood pressure in an F₂ generation of a cross between stroke-prone spontaneously hypertensive rats (SHRSP) and normotensive Wistar-Kyoto rats; (2) we treated 8-week-old SHRSP with perindopril, an angiotensin-converting enzyme inhibitor; losartan, an angiotensin type 1 receptor antagonist; or perindopril combined with a nitric oxide synthase inhibitor to investigate the relative contributions of blood pressure and angiotensin II to the pathogenesis of cardiac hypertrophy and vascular smooth muscle polyploidy. Vascular smooth muscle polyploidy was measured with flow cytometry DNA analysis. Cardiac hypertrophy was assessed by measuring the ratios of heart weight to body weight and left ventricle+septum weight to body weight. Blood pressure was measured with radiotelemetry in the F₂ cosegregation experiment and with tail-cuff plethysmography in the pharmacological study. In the F₂ rats, the best predictor of smooth muscle polyploidy by ANCOVA was systolic pressure (F=29.28, P<.0001). The ratio of left ventricle+septum weight to body weight had four major predictors: the male progenitor of the cross, sex, pulse pressure, and change in systolic pressure during salt (F=43.67, P<.0001; F=16.37, P<.0001; F=8.41, P=.0022; and F=12.39, P=.0003, respectively). The ratio of heart weight to body weight had similar predictors. In the pharmacological study, treatment with losartan alone, perindopril alone, or perindopril in combination with N^G-nitro-L-arginine methyl ester prevented the development of smooth muscle polyploidy and cardiac hypertrophy. The prevention of cardiac hypertrophy was most marked in the SHRSP treated with perindopril plus N^G-nitro-L-arginine methyl ester, despite blood pressure being higher in this group than in the two other treatment groups. We conclude that vascular and cardiac hypertrophy in this form of hypertension are regulated by different variables. However, suppression of the action of angiotensin II lessens hypertrophy of both types of muscle.

Key Words: angiotensin II • muscle, smooth, vascular • cell cycle • hypertrophy • hypertension, genetic • rats, stroke-prone SHR

This article has been cited by other articles:

				S. Jesmin, S. Zaedi, S. Maeda, H. Togashi, I. Yamaguchi, K. Goto, and T. Miyauchi Endothelin Antagonism Suppresses Plasma and Cardiac Endothelin-1 Levels in SHRSPs at the Typical Hypertensive Stage. Experimental Biology and Medicine, June 1, 2006; 231(6): 919 - 924. [Abstract] [Full Text] [PDF]

				J. Dutil, V. Eliopoulos, E.-L. Marchand, A. M. Devlin, J. Tremblay, K. Prithiviraj, P. Hamet, A. Migneault, D. deBlois, and A. Y. Deng A quantitative trait locus for aortic smooth muscle cell number acting independently of blood pressure: implicating the angiotensin receptor AT1B gene as a candidate Physiol Genomics, May 11, 2005; 21(3): 362 - 369. [Abstract] [Full Text] [PDF]

				E.-L. Marchand, S. Der Sarkissian, P. Hamet, and D. deBlois Caspase-Dependent Cell Death Mediates the Early Phase of Aortic Hypertrophy Regression in Losartan-Treated Spontaneously Hypertensive Rats Circ. Res., April 18, 2003; 92(7): 777 - 784. [Abstract] [Full Text] [PDF]

				R. J. Rooney Cell Cycle Attenuation by p120E4F Is Accompanied by Increased Mitotic Dysfunction Cell Growth Differ., October 1, 2001; 12(10): 505 - 516. [Abstract] [Full Text] [PDF]

				A. M. Devlin, J. S. Clark, J. L. Reid, and A. F. Dominiczak DNA Synthesis and Apoptosis in Smooth Muscle Cells From a Model of Genetic Hypertension Hypertension, July 1, 2000; 36(1): 110 - 115. [Abstract] [Full Text] [PDF]

				J. Zicha and J. Kunes Ontogenetic Aspects of Hypertension Development: Analysis in the Rat Physiol Rev, October 1, 1999; 79(4): 1227 - 1282. [Abstract] [Full Text] [PDF]

				N. H. Anderson, A. M. Devlin, D. Graham, J. J. Morton, C. A. Hamilton, J. L. Reid, N. J. Schork, and A. F. Dominiczak Telemetry for Cardiovascular Monitoring in a Pharmacological Study : New Approaches to Data Analysis Hypertension, January 1, 1999; 33(1): 248 - 255. [Abstract] [Full Text] [PDF]

				M. J. Brosnan, J. S. Clark, B. Jeffs, C. D. Negrin, P. Van Vooren, S. M. Arribas, H. Carswell, T. J. Aitman, C. Szpirer, I. M. Macrae, et al. Genes Encoding Atrial and Brain Natriuretic Peptides as Candidates for Sensitivity to Brain Ischemia in Stroke-Prone Hypertensive Rats Hypertension, January 1, 1999; 33(1): 290 - 297. [Abstract] [Full Text] [PDF]

				B. A. Innes, M. G. McLaughlin, M. K. Kapuscinski, H. J. Jacob, and S. B. Harrap Independent Genetic Susceptibility to Cardiac Hypertrophy in Inherited Hypertension Hypertension, March 1, 1998; 31(3): 741 - 746. [Abstract] [Full Text] [PDF]

				A. M. Devlin, M. J. Brosnan, D. Graham, J. J. Morton, A. R. McPhaden, M. McIntyre, C. A. Hamilton, J. L. Reid, and A. F. Dominiczak Vascular smooth muscle cell polyploidy and cardiomyocyte hypertrophy due to chronic NOS inhibition in vivo Am J Physiol Heart Circ Physiol, January 1, 1998; 274(1): H52 - H59. [Abstract] [Full Text] [PDF]

				D. deBlois, B.-S. Tea, T.-V. Dam, J. Tremblay, and P. Hamet Smooth Muscle Apoptosis During Vascular Regression in Spontaneously Hypertensive Rats Hypertension, January 1, 1997; 29(1): 340 - 344. [Abstract] [Full Text] [PDF]

				J. S. Clark, B. Jeffs, A. O. Davidson, W. K. Lee, N. H. Anderson, M.-T. Bihoreau, M. J. Brosnan, A. M. Devlin, A. W. Kelman, K. Lindpaintner, et al. Quantitative Trait Loci in Genetically Hypertensive Rats: Possible Sex Specificity Hypertension, November 1, 1996; 28(5): 898 - 906. [Abstract] [Full Text]

				M. L. Hixon, C. Obejero-Paz, C. Muro-Cacho, M. W. Wagner, E. Millie, J. Nagy, T. J. Hassold, and A. Gualberto Cks1 Mediates Vascular Smooth Muscle Cell Polyploidization J. Biol. Chem., December 15, 2000; 275(51): 40434 - 40442. [Abstract] [Full Text] [PDF]